Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 3 of 3 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham | |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh | |
Company Tune Therapeutics | Activity: Research and Development | Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. | Location Durham |